Allurion Technologies (ALUR) said Wednesday it expects to raise roughly $6.1 million from a registered direct share offering to institutional investors.
The company said it signed deals to sell 900,000 shares at $5.23 apiece to the investors. It will also issue warrants to the investors to buy up to 1.8 million shares.
Allurion also said it struck a deal to sell 267,686 shares and warrants to purchase up to 535,372 shares at $5.23 per share and accompanying warrant to funds affiliated with Leavitt Equity Partners.
Proceeds will be used to fund its pipeline evaluating the effects of the combination of the Allurion Balloon and GLP-1 therapy on muscle mass and long-term GLP-1 adherence, for working capital, and for general corporate purposes, the company said.
The offering is expected to close on Thursday, it said.
The shares were down more than 30% in recent trading.
Price: 3.86, Change: -1.72, Percent Change: -30.88
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。